Short-term effect of transdermal estrogen on autonomic nervous modulation in postmenopausal women

Fertility and Sterility

Volumn 84, Issue 5, 2005, Pages 1477-1483

  Chao, Hsiang Tai ^a   Kuo, Cheng Deng ^a,b   Su, Yi Ju ^a,b   Chuang, Shin Shin ^a   Fang, Ya Jing ^a   Ho, Low Tone ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Autonomic nervous modulation; Climacteric symptoms; Heart rate variability; Menopause; Transdermal estrogen

Indexed keywords

ESTRADIOL; PLACEBO;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; ESTRADIOL BLOOD LEVEL; FEMALE; FREQUENCY ANALYSIS; HEART PROTECTION; HEART RATE VARIABILITY; HUMAN; IRRITABILITY; MENOPAUSAL SYNDROME; NEUROMODULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SHORT COURSE THERAPY; TIME; UNIVERSITY HOSPITAL;

ADMINISTRATION, CUTANEOUS; AGED; AUTONOMIC NERVOUS SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTROGENS; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 27644547261     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.05.026     Document Type: Article

References (44)

1. L. Mosca, J.E. Manson, S.E. Sutherland, R.D. Langer, T. Manolio, E. Barrett-Connor Cardiovascular disease in women a statement for healthcare professionals from the American Heart Association Circulation 96 1997 2468 2482
2. M.J. Stampfer, G.A. Colditz Estrogen replacement therapy and coronary heart disease a quantitative assessment of the epidemiologic evidence Prev Med 20 1991 47 63
3. I. Virtanen, O. Polo, P. Polo-Kantola, T. Kuusela, E. Ekholm The effect of estrogen replacement therapy on cardiac autonomic regulation Maturitas 37 2000 45 51
4. G.M. Rosano, F. Leonardo, C. Dicandia, I. Sheiban, P. Pagnotta, C. Pappone Acute electrophysiologic effect of estradiol 17beta in menopausal women Am J Cardiol 86 2000 1385 1387
5. C.L. Brockbank, F. Chatterjee, S.A. Bruce, R.C. Woledge Heart rate and its variability change after the menopause Exp Physiol 85 2000 327 330
6. P. Jousilahti, E. Vartiainen, J. Tuomilehto, P. Puska Sex, age, cardiovascular risk factors, and coronary heart disease a prospective follow-up study of 14,786 middle-aged men and women in Finland Circulation 99 1999 1165 1172
7. S. Oparil, C. Arthur Corcoran memorial lecture hormones and vasoprotection Hypertension 33 1999 170 176
8. L. Niskanen, T. Laitinen, M. Tuppurainen, S. Saarikoski, H. Kroger, E. Alhava Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? Menopause 9 2002 52 57
9. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
10. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
11. M. Sillero-Arenas, M. Delgado-Rodriguez, R. Rodigues-Cateras, A. Bueno-Cavanillas, R. Galvez-Vargas Menopausal hormone replacement therapy and breast cancer a meta-analysis Obstet Gynecol 79 1992 286 294
12. B.S. Hulka Predominance of early endometrial cancers after long-term estrogen use JAMA 244 1980 2419 2422
13. K.M. Brett, J.H. Madans Use of postmenopausal hormone replacement therapy estimates from a nationally representative cohort study Am J Epidemiol 145 1997 536 545
14. T.A. Manolio, C.D. Furberg, L. Shemanski, B.M. Psaty, D.H. O'Leary, R.P. Tracy Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women Circulation 88 1993 2163 2171
15. A.A. Nabulsi, A.R. Folsom, A. White, W. Patsch, G. Heiss, K.K. Wu Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women N Engl J Med 328 1993 1069 1075
16. D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, M. Hlatky Cardiovascular disease outcomes during 6.8 years of hormone therapy Heart and Estrogen/Progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
17. D.M. Herrington, D.M. Reboussin, K.B. Brosnihan, P.C. Sharp, S.A. Shumaker, T.E. Snyder Effects of estrogen replacement on the progression of coronary-artery atherosclerosis N Engl J Med 343 2000 522 529
18. J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, N.L. Lasser Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
19. R.E. Kleiger, J.P. Miller, J.T. Bigger, A.J. Moss Decreased heart rate variability and its association with increased mortality after myocardial infarction Am J Cardiol 59 1987 256 262
20. H. Tsuji, F.J. Venditti Jr, E.S. Manders, J.C. Evans, M.G. Larson, C.L. Feldman Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study Circulation 90 1994 878 883
21. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology Heart rate variability standards of measurement, physiological interpretation, and clinical use Circulation 93 1996 1043 1065
22. C.D. Kuo, G.Y. Chen, H.M. Lo Effect of different recumbent positions on spectral indices of autonomic modulation of the heart during the acute phase of myocardial infarction Crit Care Med 28 2000 1283 1289
23. M.M. Jones, D.H. Marshall, B.E.C. Nordin Quantitation of menopausal symptomatology and its response to ethinylestradiol and piperazine oestrone sulphate Curr Med Res Opin 4 Suppl 13 1977 12 20
24. O. Odemuyiwa, M. Malik, T. Farrell, Y. Bashir, J. Poloniecki, J. Camm Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction Am J Cardiol 68 1991 434 439
25. J.T. Bigger Jr, J.L. Fleiss, R.C. Steinman, L.M. Rolnitzky, R.E. Kleiger, J.N. Rottman Frequency domain measures of heart period variability and mortality after myocardial infarction Circulation 85 1992 164 171
26. J.M. Dekker, E.G. Schouten, P. Klootwijk, J. Pool, C.A. Swenne, D. Kromhout Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men Am J Epidemiol 145 1997 899 908
27. A. Algra, J.G. Tijssen, J.R. Roelandt, J. Pool, J. Lubsen Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death Circulation 88 1993 180 185
28. J. Gmitrov, S. Andrejko Effect of verapamil on baroreflex sensitivity and on cardiovascular variability Wien Klin Wochenschr 112 2000 162 168
29. V.A. Ravnikar Compliance with hormone therapy Am J Obstet Gynecol 156 1987 1332 1334
30. J.A. Balfour, R.C. Heel Transdermal estradiol a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints Drugs 40 1990 561 581
31. A. Schuchert, M. Liebau, G. Behrens, A.O. Mueck, T. Meinertz Are the acute effects of transdermal estradiol in postmenopausal women with coronary disease related to changes of the autonomic tone? Z Kardiol 91 2002 156 160
32. W. Vongpatanasin, M. Tuncel, Y. Mansour, D. Arbique, R.G. Victor Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women Circulation 103 2001 2903 2908
33. A. Yildirir, G. Kabakci, H. Yarali, F. Aybar, E. Akgul, O. Bukulmez Effects of hormone replacement therapy on heart rate variability in postmenopausal women Ann Noninvasive Electrocardiol 6 2001 280 284
34. M.G. Kienzle, D.W. Ferguson, C.L. Birkett, G.A. Myers, W.J. Berg, D.J. Mariano Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure Am J Cardiol 69 1992 482 485
35. S.R. Lindheim, R.S. Legro, L. Bernstein, F.Z. Stanczyk, M.A. Vijod, S.C. Presser Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen Am J Obstet Gynecol 167 1992 1831 1836
36. X.J. Du, R.A. Riemersma, A.M. Dart Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function Cardiovasc Res 30 1995 161 165
37. H.V. Huikuri, S.M. Pikkujamsa, K.E. Airaksinen, M.J. Ikaheimo, A.O. Rantala, H. Kauma Sex-related differences in autonomic modulation of heart rate in middle-aged subjects Circulation 94 1996 122 125
38. L. Speroff, R.W. Whitcomb, N.J. Kempfert, R.A. Boyd, J.B. Paulissen, J.P. Rowan Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms Obstet Gynecol 88 1996 587 592
39. J.M. Sullivan, L.P. Fowlkes The clinical aspects of estrogen and the cardiovascular system Obstet Gynecol 87 1996 36S 43S
40. S.R. Lindheim, R.S. Legro, L. Bernstein, F.Z. Stanczyk, M.A. Vijod, S.C. Presser Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen Am J Obstet Gynecol 167 1992 1831 1836
41. A.O. Mueck, H. Seeger, T.H. Lippert Estradiol inhibits LDL oxidation do the progestin medroxyprogesterone acetate and norethisterone acetate influence this effect? Clin Exp Obstet Gynecol 25 1998 26 28
42. X. Zhu, B. Bonet, R.H. Knopp Estradiol 17-beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees Atherosclerosis 148 2000 31 41
43. S.G. Levrant, R.B. Barnes Pharmacology of estrogens R.A. Lobo Treatment of the postmenopausal woman basic and clinical aspects 1994 Raven Press New York 57 68
44. H.K. Genant, J. Lucas, S. Weiss, M. Akin, R. Emkey, H. McNaney-Flint Low-dose esterified estrogen therapy effects on bone, plasma estradiol concentrations, endometrium and lipid levels Arch Int Med 157 1997 2609 2615